Estimates Revisions DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.59 CNY | -0.54% |
|
+4.73% | -5.85% |
| 24/04 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 24/04 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 603233 Stock
- Consensus DaShenLin Pharmaceutical Group Co., Ltd.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
